Establishment Labs Holdings, which is a fast-growing provider of silicone breast implants, announced terms for its IPO on Monday.
The Alajuela, Costa Rica-based company plans to raise $50 million by offering 3.1 million shares at a price range of $15 to $17. At the midpoint of the proposed range, Establishment Labs Holdings would command a fully diluted market value of $320 million and an enterprise value of $294 million.
Establishment Labs Holdings was founded in 2004 and booked $43 million in sales for the 12 months ended March 31, 2018. It plans to list on the Nasdaq under the symbol ESTA. Jefferies and Cowen are the joint bookrunners on the deal. It is expected to price during the week of July 16, 2018.
